Department of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, KS 66047, United States.
Takeda Vaccines Inc., Cambridge, MA 02139, United States.
Vaccine. 2018 May 24;36(22):3169-3179. doi: 10.1016/j.vaccine.2017.04.086. Epub 2017 May 12.
A combination experimental approach, utilizing semi-empirical excipient screening followed by statistical modeling using design of experiments (DOE), was undertaken to identify stabilizing candidate formulations for a lyophilized live attenuated Flavivirus vaccine candidate. Various potential pharmaceutical compounds used in either marketed or investigative live attenuated viral vaccine formulations were first identified. The ability of additives from different categories of excipients, either alone or in combination, were then evaluated for their ability to stabilize virus against freeze-thaw, freeze-drying, and accelerated storage (25°C) stresses by measuring infectious virus titer. An exploratory data analysis and predictive DOE modeling approach was subsequently undertaken to gain a better understanding of the interplay between the key excipients and stability of virus as well as to determine which combinations were interacting to improve virus stability. The lead excipient combinations were identified and tested for stabilizing effects using a tetravalent mixture of viruses in accelerated and real time (2-8°C) stability studies. This work demonstrates the utility of combining semi-empirical excipient screening and DOE experimental design strategies in the formulation development of lyophilized live attenuated viral vaccine candidates.
采用半经验赋形剂筛选,然后利用实验设计(DOE)进行统计建模,开展了一项组合实验方法,旨在确定冻干减毒活病毒候选疫苗的稳定候选配方。首先确定了各种用于市售或研究性减毒活病毒疫苗配方的潜在药物化合物。然后,评估了来自不同类别赋形剂的添加剂单独或组合使用时,通过测量感染性病毒滴度,其抵抗冻融、冷冻干燥和加速储存(25°C)压力的能力。随后进行了探索性数据分析和预测性 DOE 建模方法,以更好地了解关键赋形剂与病毒稳定性之间的相互作用,并确定哪些组合在相互作用以提高病毒稳定性。确定了主要赋形剂组合,并使用加速和实时(2-8°C)稳定性研究中的四价病毒混合物进行了稳定效果测试。这项工作证明了在冻干减毒活病毒候选疫苗的配方开发中,结合半经验赋形剂筛选和 DOE 实验设计策略的实用性。